Pugliano C, Berger M, Ray R, Sapkos K, Wu B, Laird A
Mol Ther Methods Clin Dev. 2025; 32(3):101297.
PMID: 40012884
PMC: 11863497.
DOI: 10.1016/j.omtm.2024.101297.
Bushman J, Potts P
Nature. 2025; 639(8053):42-43.
PMID: 39966588
DOI: 10.1038/d41586-025-00090-7.
Xie X, Zhang O, Yeo M, Lee C, Tao R, Harry S
Nature. 2025; 639(8053):241-249.
PMID: 39939763
PMC: 11882451.
DOI: 10.1038/s41586-024-08533-3.
Yeo M, Zhang O, Xie X, Nam E, Payne N, Gosavi P
Nature. 2025; 639(8053):232-240.
PMID: 39939761
PMC: 11882444.
DOI: 10.1038/s41586-024-08532-4.
Coulombe P, Tomellini E, Chagraoui J, Mayotte N, Sauvageau G
Nat Commun. 2025; 16(1):195.
PMID: 39747844
PMC: 11696577.
DOI: 10.1038/s41467-024-55225-7.
Chemical perturbations impacting histone acetylation govern colorectal cancer differentiation.
Likasitwatanakul P, Li Z, Doan P, Spisak S, Raghawan A, Liu Q
bioRxiv. 2024; .
PMID: 39713466
PMC: 11661112.
DOI: 10.1101/2024.12.06.626451.
Modification of Lhx2 activity for amplification of human iPSC-derived hematopoietic stem/progenitor cells.
Kitajima K, Takahashi Y, Ando H, Shingai M, Hamasaki M, Tanikawa M
Front Cell Dev Biol. 2024; 12:1482989.
PMID: 39474350
PMC: 11518812.
DOI: 10.3389/fcell.2024.1482989.
UM171 enhances fitness and engraftment of gene-modified hematopoietic stem cells from patients with sickle cell disease.
Liu B, Klatt D, Zhou Y, Manis J, Sauvageau G, Pellin D
Blood Adv. 2024; 8(22):5885-5895.
PMID: 39293082
PMC: 11612367.
DOI: 10.1182/bloodadvances.2024013932.
Umbilical cord blood derived cell expansion: a potential neuroprotective therapy.
Penny T, Jenkin G, Miller S, McDonald C
Stem Cell Res Ther. 2024; 15(1):234.
PMID: 39075614
PMC: 11287950.
DOI: 10.1186/s13287-024-03830-0.
How aging influences the gut-bone marrow axis and alters hematopoietic stem cell regulation.
Wells C, Robertson T, Sheth P, Abraham S
Heliyon. 2024; 10(12):e32831.
PMID: 38984298
PMC: 11231543.
DOI: 10.1016/j.heliyon.2024.e32831.
Utilizing epigenetic regulators to improve HSC-based lentiviral gene therapy.
Tajer P, Karakaslar E, Cante-Barrett K, Naber B, Vloemans S, van Eggermond M
Blood Adv. 2024; 8(18):4936-4947.
PMID: 38916861
PMC: 11421325.
DOI: 10.1182/bloodadvances.2024013047.
UM171 suppresses breast cancer progression by inducing KLF2.
Ran X, Hu A, Kuang Y, Wang C, Liu W, Xiao X
Breast Cancer Res Treat. 2024; 207(2):405-415.
PMID: 38874684
PMC: 11297059.
DOI: 10.1007/s10549-024-07372-0.
An autoinhibitory switch of the LSD1 disordered region controls enhancer silencing.
Waterbury A, Kwok H, Lee C, Narducci D, Freedy A, Su C
Mol Cell. 2024; 84(12):2238-2254.e11.
PMID: 38870936
PMC: 11193646.
DOI: 10.1016/j.molcel.2024.05.017.
Engineering an inducible leukemia-associated fusion protein enables large-scale ex vivo production of functional human phagocytes.
Windisch R, Soliman S, Hoffmann A, Chen-Wichmann L, Danese A, Vosberg S
Proc Natl Acad Sci U S A. 2024; 121(25):e2312499121.
PMID: 38857395
PMC: 11194515.
DOI: 10.1073/pnas.2312499121.
Advances in ex vivo expansion of hematopoietic stem and progenitor cells for clinical applications.
Branco A, Rayabaram J, Miranda C, Fernandes-Platzgummer A, Fernandes T, Sajja S
Front Bioeng Biotechnol. 2024; 12:1380950.
PMID: 38846805
PMC: 11153805.
DOI: 10.3389/fbioe.2024.1380950.
MYCT1 controls environmental sensing in human haematopoietic stem cells.
Aguade-Gorgorio J, Jami-Alahmadi Y, Calvanese V, Kardouh M, Fares I, Johnson H
Nature. 2024; 630(8016):412-420.
PMID: 38839950
PMC: 11168926.
DOI: 10.1038/s41586-024-07478-x.
Near-perfect precise on-target editing of human hematopoietic stem and progenitor cells.
Cloarec-Ung F, Beaulieu J, Suthananthan A, Lehnertz B, Sauvageau G, Sheppard H
Elife. 2024; 12.
PMID: 38829685
PMC: 11147503.
DOI: 10.7554/eLife.91288.
Adaptation to ex vivo culture reduces human hematopoietic stem cell activity independently of the cell cycle.
Johnson C, Williams M, Sham K, Belluschi S, Ma W, Wang X
Blood. 2024; 144(7):729-741.
PMID: 38805639
PMC: 7616366.
DOI: 10.1182/blood.2023021426.
Advances in hematopoietic stem cells ex vivo expansion associated with bone marrow niche.
Deng J, Tan Y, Xu Z, Wang H
Ann Hematol. 2024; 103(12):5035-5057.
PMID: 38684510
DOI: 10.1007/s00277-024-05773-1.
Lentivirus-Mediated BCL-X Overexpression Inhibits Stem Cell Apoptosis during Ex Vivo Expansion and Provides Competitive Advantage Following Xenotransplantation.
Zehnle P, Wu Y, Koleci N, Bohler S, Erlacher M
Int J Mol Sci. 2024; 25(7).
PMID: 38612914
PMC: 11012376.
DOI: 10.3390/ijms25074105.